ĀLTIKABIOTECH
ĀLTIKA BIOTECH

Powering
the clean edge.

Australian innovation with industrial purpose.
Advancing a new way to make solid-state battery materials.

Explore BSSF Meet Āltika
Research-stage technology / Evidence update: 29 October 2026
01 / MOLECULAR DESIGNConceptual visualisation · not experimental imagery
Conceptual peptide scaffold from the WA Battery Summit pitch
BSSF / FROM INFORMATION TO MATTER

A molecule.
A forming structure.
A manufacturing question.

Follow the proposed journey from molecular guidance to an electrolyte layer, and discover what the laboratory must establish.

Follow the material ↗

Conceptual scaffold · not a molecular simulation or experimental image

94%

Supplier-reported
peptide purity

ECU

Research collaboration
Physical validation programme

A$2.19bn

Modelled annual value
per 100 GWh factory*

Progress with
evidence
A DIFFERENT MANUFACTURING QUESTION

What if the material
could change
the process?

Āltika is investigating a biological approach to a demanding industrial challenge: forming a solid-state electrolyte without conventional high-temperature sintering.

BSSF uses a designed peptide to guide material formation. The ambition is a simpler manufacturing route, with less dependence on furnace infrastructure. The physical research programme will determine what the approach can deliver.

Inside the BSSF programme
Illustrative material characterisation apparatus from the summit pitch
Illustrative laboratory · not a photograph of the peptide or ECU facility
THE PHYSICAL MILESTONE

From molecular design.
To a physical peptide.

Australian supplier Auspep has synthesised the proprietary peptide, with reported purity of 94% against a 90% specification.

A tangible step forward. Electrolyte conductivity, stability and cell performance remain to be established through experiments.

Follow the evidence
ĀLTIKA BIOTECH · OWNED BY HOWE INVEST PTY LTD

Ideas with an
industrial destination.

Discover Āltika
THE BIOTECH PLATFORM

Āltika Biotech

Peptide and enzyme design, advanced materials and biotechnology research with practical purpose.

↗OUR OWNER

Howe Invest

Company ownership, governance and the commercial support behind Āltika’s research and development.

↗
THE PROPOSED MANUFACTURING ADVANTAGE

A$2.19 billion.

Potential annual manufacturer value.
Per 100 GWh factory.

Explore the assumptions
Reference oxide processA$31.90/kWh
BSSF process targetA$10.00/kWh

*Illustrative company model, not measured savings or a forecast. Assumes successful validation and 100 GWh annual output. This is manufacturer value, not company revenue. Integration, financing, tax and timing effects are excluded.

ĀLTIKA BIOTECH · COMPANY PROFILE

The platform. The progress.
The opportunity.

A concise introduction to Āltika, its BSSF research programme and its owner, Howe Invest Pty Ltd.

Download company profile

PDF · 2 pages · November 2026
Public overview · Research status dated 29 October 2026

RESEARCH. INDUSTRY. POSSIBILITY.

Build the next chapter with us.

Start a conversation